What type of cytopathic effect (CPE) would be expected in a viral culture for a patient with symptoms of genital herpes, such as vesicular and ulcerative lesions, and mild pleocytosis in the cerebrospinal fluid (CSF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cytopathic Effect in Herpes Simplex Virus Culture

The characteristic cytopathic effect (CPE) expected in viral culture for this patient with genital herpes would show ballooning of infected cells with multinucleation and intranuclear inclusion bodies, typically appearing within 24-72 hours after inoculation.

Viral Culture Findings in HSV Infection

HSV viral culture remains a cornerstone diagnostic method for herpes infections, particularly when PCR is unavailable. When examining the cytopathic effects in cell culture:

  • Timing of CPE appearance: The characteristic cytopathic effect generally appears within 24-72 hours, but may take up to five days 1
  • Early changes: As early as 4 hours post-infection, stereological studies show approximately 53% increase in nuclear volume and 46% increase in cell volume compared to uninfected cells 2
  • Cellular morphology:
    • Ballooning/enlargement of infected cells
    • Formation of multinucleated giant cells (syncytia), which becomes particularly remarkable 48 hours post-infection 3
    • Intranuclear inclusion bodies (Cowdry type A inclusions)
    • Ground-glass appearance of nuclei

Cell Lines Used for HSV Culture

Common cell lines used for HSV culture include:

  • Primary human fibroblasts
  • MRC-5 cells
  • Vero cells
  • Baby hamster kidney cells
  • Rabbit kidney cells 1

MRC-5 and rhabdomyosarcoma (RD) cells are equally sensitive for HSV detection, though early CPE may be easier to detect in MRC-5 cells 4.

Diagnostic Pitfalls

When examining viral cultures for HSV, be aware of these potential pitfalls:

  • Only a minority of cases (28%) may show numerous cells with classic viral cytopathic changes 5
  • Inflammation may obscure cytologic findings (severe in 22% of cases) 5
  • Blood and degenerative changes can mask viral cytopathic effects 5
  • Some HSV strains, particularly those from patients on acyclovir therapy, may not produce typical CPE even after 120 hours post-infection 6

Clinical Context

In this 20-year-old female patient, the clinical presentation strongly suggests primary genital herpes with meningeal involvement:

  • Vesicular and ulcerative genital lesions
  • Systemic symptoms (fever, chills, myalgias)
  • Neurological symptoms (headache, photophobia, stiff neck)
  • CSF showing mild pleocytosis with mononuclear cell predominance
  • Rapid response to antiviral therapy

Typing of HSV Using Cell Culture

Typing of HSV using cell culture can be performed directly on infected cell cultures using:

  • Fluorescein isothiocyanate (FITC)-labeled type-specific monoclonal antibodies
  • Immunoperoxidase-labeled type-specific monoclonal antibodies
  • Testing the cell supernatant by nucleic acid amplification tests (NAATs) with specifically designed primers 1

While PCR is now considered the gold standard for HSV detection with superior sensitivity, viral culture remains valuable as it demonstrates active infection and allows for antiviral sensitivity testing 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.